AffiAB®​ PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, 0.1mg/mL Antibody

https://www.affiab.com/web/image/product.template/489345/image_1920?unique=d31c23b
(0 review)

CAT# AFG-BTM-16579
Size: 100 μL

380.40 380.40000000000003 USD 380.40

380.40

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

PD-L1 (also known as Programmed Death Ligand 1, CD274, and B7-H1) is one of two cell surface ligands that engage the negative regulatory T cell surface receptor PD-1. PD-L1 is a Type I transmembrane protein expressed on the plasma membrane of cells, such as activated macrophages and some tumor cells. Because binding of PD-1 by PD-L1 has a suppressive effect on the immune system, inhibition of the PD-1/PD-L1 pathway is a major strategy of immune-oncology therapies. PD-L1 is upregulated in certain cancers, and blocking PD-1 or PD-L1 can inhibit cancer growth. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors. .

Conjugate

CF488A.

Concentration

0.1 mg/mL.

Storage Buffer

PBS, 0.1% BSA, 0.05% azide.

Product Applications

Flow, surface (verified) |IF (verified) |IHC, FFPE (verified) |WB (verified) .

Storage Temperature

2°C to 8°C.

Stability

Stable at room temperature or 37°C (98°F) for 7 days.